AFT PHARMACEUTICALS LIMITED - News & Media

0.33%

$3.01

Market Cap $314.5M

Healthcare Drug Manufacturers - Specialty & Generic

AFT Pharmaceuticals (ASX:AFP) are a growing multinational pharmaceutical company that... AFT Pharmaceuticals (ASX:AFP) are a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital.More

Corporate Spotlight

AFT Pharmaceuticals (ASX:AFP) are a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels.
View the full Corporate Spotlight

AFP TARGETING $6 BILLION OPPORTUNITY

Articles & Videos

Fridge-free drugs, global markets: How AFT are targeting a $6 billion opportunity

Welcome to the HotCopper Watchlist, where today we’ve spoken to AFT Pharmaceuticals (ASX:AFP) chief and founder Hartley Atkinson to discuss R@D on a @promising” new product and entry into the Canadian stock market.Listen to the HotCopper podcast for in-depth ...

7 days ago

AFT Pharmaceuticals jumps +10% on $115M interim FY26 record revenue

AFT Pharmaceuticals has seen its price jump +10% just shy of $3/sh on Thursday morning as the company reveals record revenues.

20 Nov 2025 11:02 (AEDT)

AFT Pharma unveils record revenues of $115 million on global expansion

AFT Pharma has this week unveiled impressive first calendar half results, with revenues up 33% to just south of $115 million.

20 Nov 2025 09:45 (AEDT)

Listen: From the Wire – AFT Pharmaceuticals CEO and Founder Hartley Atkinson

In this episode of HotCopper's From the Wire, AFT Pharma founder Hartley Atkinson sits down with senior markets reporter Jonathon Davidson.

27 Oct 2025 17:00 (AEDT)

AFT Pharma: FY27 revenue expected to hit $300M, positive iron IV results in

AFT Pharmaceuticals (ASX:AFP) founder and CEO Hartley Atkinson joined HotCopper to discuss the company’s September 25 report, including its good progress towards its goal to have $300 million annual revenue in FY27.Listen to the HotCopper podcast for in-depth discussions and insig...

25 Sep 2025 09:13 (AEST)

AFT Pharmaceuticals outlines shareholder value focus in 2025 AGM

At its annual shareholders meeting in Auckland today, AFT Pharmaceuticals (ASX:AFP) laid out its plans to leverage the company’s R@D pipeline as it hunts out new addressable markets worth as much as US$8 billion.Listen to the HotCopper podcast for in-depth discussions and insights...

01 Aug 2025 11:00 (AEST)

AFT Pharmaceuticals launches Combogesic IV in Canada

AFT Pharmaceuticals has @lots of exciting things happening” as FY26 begins, not least Combogesic IV launching in Canada as the New Zealand pharma company looks to build its presence in North America in coming months and years.Listen to the HotCopper podcast for in-depth disc...

01 Jul 2025 09:48 (AEST)

Reshaped Combogesic deal sets 'pleased' AFT Pharma up to answer US demand

New Zealand drug maker AFT Pharmaceuticals (ASX:AFP) will continue working with United States distributor Hikma Pharmaceuticals to sell key products in the U.S. after the two biotech companies put pen to paper on a new deal.Listen to the HotCopper podcast for in-depth discussions and insights on ...

26 May 2025 14:56 (AEST)

AFT Pharma sets new $300M target after reaching $200M revenue for FY25

AFT Pharmaceuticals Ltd has unveiled its financial results for FY2025, announcing that it has reached a revenue of more than $200M

22 May 2025 09:33 (AEST)

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals

With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks...

14 May 2025 10:40 (AEST)

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $3.01		Change 0.010(0.33%)		Mkt cap ! $314.5M

Open	High	Low	Volume
$3.01	$3.01	$3.01	5

Buyers (Bids)

Vol.	Price($)
9	$3.01

Sellers (Offers)

Price($)	Vol.
$2.98	1

Last trade - 09.59am 21/01/2026 (20 minute delay)

AFP (ASX) Chart